Home › Funds › Compagnie Lombard Odier SCmA › ABT

Compagnie Lombard Odier SCmA position in ABT

ABBOTT LABORATORIES · Health Care

Compagnie Lombard Odier SCmA reported holding 542,153 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$53.6M, representing 0.66% of its reported portfolio and ranking #31 among its reported holdings. Compagnie Lombard Odier SCmA has disclosed ABT holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)542.15K sh
Reported value held$53.58M
Portfolio Weight0.66%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Compagnie Lombard Odier SCmA's ABT position evolved

Compagnie Lombard Odier SCmA first disclosed a stake in ABT in Q3 2023 at 782,305 shares (US$75.8M). The position peaked in Q1 2025 at 754,559 shares, worth US$100.1M. Across 6 filings, Compagnie Lombard Odier SCmA increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 542,153 shares valued at US$53.6M — an increase of 109,335 shares quarter over quarter.. Notable position changes include a 25% increase in Q3 2026 (shares rose 11% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 782.30K $75.77M New
Q4 2023 833.30K $91.72M Add
Q1 2025 754.56K $100.09M New
Q4 2025 675.06K $84.58M New
Q2 2026 432.82K $39.27M New
Q3 2026 542.15K $53.58M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has Compagnie Lombard Odier SCmA held ABT?

Compagnie Lombard Odier SCmA has disclosed ABT holdings in 6 of the last 13 reported quarters, going back to Q3 2023.

What is Compagnie Lombard Odier SCmA's current position in ABT?

As of Q3 2026, Compagnie Lombard Odier SCmA holds 542.15K shares of ABT (ABBOTT LABORATORIES), valued at $53.58M, representing 0.66% of its reported portfolio and ranking #31.

Has Compagnie Lombard Odier SCmA been buying or selling ABT?

In the latest 13F filing (Q3 2026), Compagnie Lombard Odier SCmA increased its position in ABT. The position peaked in Q1 2025 at 754.56K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.